SCHEMBL4810401

SCHEMBL4810401

CCOC(=O)C1(C)CCCC1OC(=O)c1cccc(C)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 1/20 0.44
PTPN1 P18031 1/20 0.44
CDC25B P30305 1/20 0.44
NPC1 O15118 4/20 0.42
RAB9A P51151 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
NPSR1 Q6W5P4 2/20 0.42
F10 P00742 2/20 0.39
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
ADRB3 P13945 1/20 0.39
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MAPT P10636 1/20 0.37
GRM5 P41594 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4806457 0.90 SMN1; SMN2 (0.44) NPC1RAB9ASMN1; SMN2NPSR1ADRB2
SCHEMBL4811231 0.89 ADRB2 (0.43) PTPN2PTPN1CDC25BNPC1RAB9A
SCHEMBL4810742 0.88 PTPN2 (0.49) PTPN2PTPN1CDC25BSMN1; SMN2NPSR1
SCHEMBL4812218 0.86 PTPN2 (0.52) PTPN2PTPN1CDC25BNPC1RAB9A
SCHEMBL4813834 0.85 NPC1 (0.41) PTPN2PTPN1CDC25BNPC1RAB9A
SCHEMBL4811526 0.84 ADRB2 (0.42) NPC1RAB9ASMN1; SMN2NPSR1ADRB2
SCHEMBL4814848 0.84 NPC1 (0.40) NPC1RAB9ASMN1; SMN2NPSR1ADRB2
SCHEMBL4813857 0.84 NPC1 (0.40) NPC1RAB9ASMN1; SMN2NPSR1ADRB2
SCHEMBL4808103 0.83 NPSR1 (0.39) NPC1RAB9ASMN1; SMN2NPSR1ADRB2
SCHEMBL4804183 0.83 NPC1 (0.42) NPC1RAB9ASMN1; SMN2NPSR1ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7388103-B2 Cyclopentane carboxylate compounds, process and intermediates for preparing the same and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2008-06-17 US disclosed
US-20060094843-A1 Cyclopentane carboxylate compounds, process and intermediates for preparing the same and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2006-05-04 US disclosed
WO-2006045246-A1 CYCLOPENTANE CARBOXYLATE COMPOUNDS, PROCESS AND INTERMEDIATES FOR PREPARING THE SAME AND USE THEREOF CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060094843-A1 Cyclopentane carboxylate compounds, process and intermediates for preparing the same and use thereof C5, C1S, AKR1C3 PTPN2 3885/4885PTPN1 3877/4885CDC25B 1406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.